Nuo Therapeutics, Inc. (AURX)

Investing Cash Flow

-$253.03K

Quarterly · Period ending: · USD

AURX logo

AURX Investing Cash Flow

Latest reported-$253.03K
AURX Quarterly Cash from Investing (-$140.66K → -$253.03K)
High-resolution chart · PNG

AURX investing cash flow history

Quarterly · USD. Dates are reporting period ends; fiscal years can differ from calendar years.

Nuo Therapeutics, Inc. Investing Cash Flow — Quarterly (USD)
Period endingInvesting Cash Flow (USD)
-253,027
-847
-43,205
0
-1,667
-229,884
0
-150,862
-4,100
0
0
-1,901
0
-5,343
-4,649
-3,808
-39,687
-11,848
0
0
0
0
0
0
0
0
0
0
2,000,000,000
0
2,000
0
50,008
0
5,430
0
99,986
0
0
0
-388,074
-100,907
25,404
-165,817
-273,500
-33,319
33,357
-75,733
-150,324
1,706,501
-149,996
-17,206
-215,221
-635,328
-594,959
-146,202
-61,564
39,370
37,400
7,615
-735,525
62,050
-2,046,518
0
-172
-2,050
-52,500
-27,474
-16,391
-54,980
-352
-9,990
-15,509
0
1,600
0
1,500
0
3,000
0
11,100
27,675
0
21,375
-25,538
-22,507
-6,918
-2,200
-774
-11,653
-1,250
0
-177,709
-98,438
-22,124
-6,600
0
0
192,579
-2,483,624
Data is provided for informational purposes only and does not constitute investment advice. Past performance is not indicative of future results.